The 3,600 sqft facility will help develop the MIMIX sustained-release intradermal microneedle patch, which is planned for proof-of-concept trials for COVID-19 in 2022
As cleanroom technology evolves, so does the need for new perspectives. The Cleanroom Technology Conference 2026 invites innovators and industry experts to share new ideas,...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.